Activation of spinal cord neural stem cells(NSCs)and subsequent neurogenesis holds a promising alternative for spinal cord injury(SCI)repair.Our previous study demonstrated that complement C3a,derived from reactive as...Activation of spinal cord neural stem cells(NSCs)and subsequent neurogenesis holds a promising alternative for spinal cord injury(SCI)repair.Our previous study demonstrated that complement C3a,derived from reactive astrocytes,inhibits NSC proliferation by suppressing protein aggregate clearance through the deubiquitinating enzyme ubiquitin carboxy-terminal hydrolase L1(UCHL1)-proteasome system post-SCI.However,the potential molecular mechanism by which C3a modulates NSC activation via this pathway remains unclear.Here,we revealed that C3a/C3a receptor(C3aR)signaling activated NF-κB p65,which in turn inhibited Nrf2 activity and UCHL1 expression,resulting in diminished proteasome activity and the accumulation of protein aggregates,and ultimately impaired NSC activation.Both knockdown of NF-κB p65 and Nrf2 upregulation restored UCHL1 expression and proteasome activity in vitro,promoting NSC activation by enhancing protein aggregate clearance.Mechanistically,we found that NF-κB p65 regulated Nrf2 activity through a dual mechanism:(1)promoting Keap1-dependent ubiquitination and proteasome degradation of Nrf2;(2)inhibiting protein kinase C-mediated Nrf2 phosphorylation and nuclear translocation.Using the dual-luciferase reporter assay and chromatin immunoprecipitation(ChIP)analysis,we further identified UCHL1 as a direct transcriptional target of Nrf2.Importantly,in vivo experiments using SCI mice confirmed that either C3aR blockade,NF-κB p65 knockdown,or Nrf2 overexpression could rescue SCI-induced UCHL1 downregulation.Together,this study uncovers the C3a-NF-κB p65-Nrf2-UCHL1-proteasome axis as a critical regulator of NSC activation after SCI.This may provide novel molecular targets and intervention strategies for SCI repair.展开更多
设计并合成了一种交叉共轭的(cross-conjugated)缺电子型聚合物单体——二溴代噻吩[2,3-b]并噻吩-吡咯[3,4-c]并吡咯(DPPTTZ)二酮,并将其分别与噻吩(T)、硒吩(Se)和N-甲基吡咯(Py)的双锡试剂进行共聚反应,获得了一类新的供体-受体(D-A)...设计并合成了一种交叉共轭的(cross-conjugated)缺电子型聚合物单体——二溴代噻吩[2,3-b]并噻吩-吡咯[3,4-c]并吡咯(DPPTTZ)二酮,并将其分别与噻吩(T)、硒吩(Se)和N-甲基吡咯(Py)的双锡试剂进行共聚反应,获得了一类新的供体-受体(D-A)型共轭聚合物光电材料.这类材料分子的最高占有轨道(HOMO)能级较低,因此其光电器件具有较高的开路电压(Voc),稳定性好.此外,它们在紫外-可见光区有较宽的吸收,最大吸收位于波长620 nm附近;能带隙(band gap)小,分别为1.86 e V(p DPPTTZ-T)、1.83 e V(p DPPTTZ-Se)和1.85 e V(p DPPTTZ-Py).器件初步测试结果表明,上述聚合物与PC71BM组成的本体异质结聚合物太阳能电池Voc在0.68~0.81 V之间,能量转化效率(PCE)最高达3.05%(p DPPTTZ-T).展开更多
基金supported by the National Natural Science Foundation of China(82071362 and 82270669)Key Project of the Regional Joint Fund of Guangdong Province(2023B1515120077)+3 种基金Basic Research Program of Shenzhen Science and Technology Innovation Commission(JCYJ20210324123001003 and JCYJ20220530144801003)Shenzhen Key Laboratory of Bone Tissue Repair and Translational Research(ZDSYS20230626091402006)the Innovation and Entrepreneurship Training Program for College Students,Sun Yat-sen University(20242150)the Leading Innovation and Entrepreneurship Team Program of Zhejiang Province,China(2023R01005).
文摘Activation of spinal cord neural stem cells(NSCs)and subsequent neurogenesis holds a promising alternative for spinal cord injury(SCI)repair.Our previous study demonstrated that complement C3a,derived from reactive astrocytes,inhibits NSC proliferation by suppressing protein aggregate clearance through the deubiquitinating enzyme ubiquitin carboxy-terminal hydrolase L1(UCHL1)-proteasome system post-SCI.However,the potential molecular mechanism by which C3a modulates NSC activation via this pathway remains unclear.Here,we revealed that C3a/C3a receptor(C3aR)signaling activated NF-κB p65,which in turn inhibited Nrf2 activity and UCHL1 expression,resulting in diminished proteasome activity and the accumulation of protein aggregates,and ultimately impaired NSC activation.Both knockdown of NF-κB p65 and Nrf2 upregulation restored UCHL1 expression and proteasome activity in vitro,promoting NSC activation by enhancing protein aggregate clearance.Mechanistically,we found that NF-κB p65 regulated Nrf2 activity through a dual mechanism:(1)promoting Keap1-dependent ubiquitination and proteasome degradation of Nrf2;(2)inhibiting protein kinase C-mediated Nrf2 phosphorylation and nuclear translocation.Using the dual-luciferase reporter assay and chromatin immunoprecipitation(ChIP)analysis,we further identified UCHL1 as a direct transcriptional target of Nrf2.Importantly,in vivo experiments using SCI mice confirmed that either C3aR blockade,NF-κB p65 knockdown,or Nrf2 overexpression could rescue SCI-induced UCHL1 downregulation.Together,this study uncovers the C3a-NF-κB p65-Nrf2-UCHL1-proteasome axis as a critical regulator of NSC activation after SCI.This may provide novel molecular targets and intervention strategies for SCI repair.
文摘设计并合成了一种交叉共轭的(cross-conjugated)缺电子型聚合物单体——二溴代噻吩[2,3-b]并噻吩-吡咯[3,4-c]并吡咯(DPPTTZ)二酮,并将其分别与噻吩(T)、硒吩(Se)和N-甲基吡咯(Py)的双锡试剂进行共聚反应,获得了一类新的供体-受体(D-A)型共轭聚合物光电材料.这类材料分子的最高占有轨道(HOMO)能级较低,因此其光电器件具有较高的开路电压(Voc),稳定性好.此外,它们在紫外-可见光区有较宽的吸收,最大吸收位于波长620 nm附近;能带隙(band gap)小,分别为1.86 e V(p DPPTTZ-T)、1.83 e V(p DPPTTZ-Se)和1.85 e V(p DPPTTZ-Py).器件初步测试结果表明,上述聚合物与PC71BM组成的本体异质结聚合物太阳能电池Voc在0.68~0.81 V之间,能量转化效率(PCE)最高达3.05%(p DPPTTZ-T).